HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic defects in the hexosamine and sialic acid biosynthesis pathway.

AbstractBACKGROUND:
Congenital disorders of glycosylation are caused by defects in the glycosylation of proteins and lipids. Classically, gene defects with multisystem disease have been identified in the ubiquitously expressed glycosyltransferases required for protein N-glycosylation. An increasing number of defects are being described in sugar supply pathways for protein glycosylation with tissue-restricted clinical symptoms.
SCOPE OF REVIEW:
In this review, we address the hexosamine and sialic acid biosynthesis pathways in sugar metabolism. GFPT1, PGM3 and GNE are essential for synthesis of nucleotide sugars uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) and cytidine-5'-monophospho-N-acetylneuraminic acid (CMP-sialic acid) as precursors for various glycosylation pathways. Defects in these enzymes result in contrasting clinical phenotypes of congenital myasthenia, immunodeficiency or adult-onset myopathy, respectively. We therefore discuss the biochemical mechanisms of known genetic defects in the hexosamine and CMP-sialic acid synthesis pathway in relation to the clinical phenotypes.
MAJOR CONCLUSIONS:
Both UDP-GlcNAc and CMP-sialic acid are important precursors for diverse protein glycosylation reactions and for conversion into other nucleotide-sugars. Defects in the synthesis of these nucleotide sugars might affect a wide range of protein glycosylation reactions. Involvement of multiple glycosylation pathways might contribute to disease phenotype, but the currently available biochemical information on sugar metabolism is insufficient to understand why defects in these pathways present with tissue-specific phenotypes.
GENERAL SIGNIFICANCE:
Future research on the interplay between sugar metabolism and different glycosylation pathways in a tissue- and cell-specific manner will contribute to elucidation of disease mechanisms and will create new opportunities for therapeutic intervention. This article is part of a Special Issue entitled "Glycans in personalised medicine" Guest Editor: Professor Gordan Lauc.
AuthorsAnke P Willems, Baziel G M van Engelen, Dirk J Lefeber
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1860 Issue 8 Pg. 1640-54 (Aug 2016) ISSN: 0006-3002 [Print] Netherlands
PMID26721333 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Glycoproteins
  • Hexosamines
  • GFPT1 protein, human
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
  • PGM3 protein, human
  • Phosphoglucomutase
  • N-Acetylneuraminic Acid
Topics
  • Adult
  • Carbohydrate Metabolism, Inborn Errors (genetics, metabolism)
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) (genetics, metabolism)
  • Glycoproteins (genetics, metabolism)
  • Glycosylation
  • Hexosamines (genetics, metabolism)
  • Humans
  • N-Acetylneuraminic Acid (genetics, metabolism)
  • Phosphoglucomutase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: